Providing Brain Control of Extracorporeal Devices to Patients With Quadriplegia

NACompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

January 31, 2019

Study Completion Date

January 31, 2019

Conditions
Tetraplegia
Interventions
DEVICE

Neural Prosthetic System

The Neural Prosthetic System is primarily composed of two NeuroPort Arrays. Each array is comprised of 100 microelectrodes (1.5 mm in length) uniformly organized on a 4 mm x 4 mm silicon base that is 0.25 mm thick. Each microelectrode is insulated with Parylene-C polymer and is electrically isolated from neighboring electrodes by non-conducting glass. Each microelectrode has a platinum tip that is 100-200 microns in length and offers impedance values from 100-800 kilo-ohms. Of the 100 electrodes, 96 are wire bonded using 25 micron gold alloy insulated wires collectively sealed with a silicone elastomer. The wire bundle is potted to a printed circuit board with epoxy, the printed circuit board is inserted into the Patient Pedestal (percutaneous connector), and then the Patient Pedestal is filled with silicone elastomer. Two fine platinum reference wires are also attached to the Patient Pedestal. The Patient Pedestal is 19 mm wide at the skin interface.

Trial Locations (3)

90033

University of Southern California, Los Angeles

90242

Rancho Los Amigos National Rehabilitation Center, Downey

91125

California Institute of Technology, Pasadena

All Listed Sponsors
collaborator

University of Southern California

OTHER

collaborator

Rancho Los Amigos National Rehabilitation Center

OTHER

lead

Richard A. Andersen, PhD

OTHER

NCT01849822 - Providing Brain Control of Extracorporeal Devices to Patients With Quadriplegia | Biotech Hunter | Biotech Hunter